← FDA DRUG APPROVALS

FDA NDA · NDA016818

EMETE-CON

Sponsor: ROERIG

APPLICATION
NDA016818
TYPE
NDA
ORIGINAL APPROVAL
1978-09-27
LATEST ACTION
1997-06-25
ROUTE
RECTAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Discontinued

Products

EMETE-CONDiscontinued
BENZQUINAMIDE HYDROCHLORIDE EQ 100MG BASE · SUPPOSITORY · RECTAL

Approval history

1997-06-25Labeling · Supplement 1AP
1978-09-27Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →